STERILE WATER- water injection, solution 
Hikma Pharmaceuticals USA Inc.

----------

Sterile Water for Injection, USP

Rx only

DESCRIPTION

This preparation is designed solely for parenteral use only after addition of drugs that require dilution or must be dissolved in an aqueous vehicle prior to injection.

Sterile Water for Injection, USP is a sterile, nonpyrogenic preparation of water for injection which contains no bacteriostat, antimicrobial agent or added buffer and is supplied only in single-dose containers to dilute or dissolve drugs for injection. For intravenous injection, add sufficient solute to make an approximately isotonic solution.

Water for Injection, USP is chemically designated H2O.

The glass vial is a Type I borosilicate glass and meets the requirements according to the USP standards.

CLINICAL PHARMACOLOGY

Water is an essential constituent of all body tissues and accounts for approximately 70% of total body weight. Average normal adult daily requirement ranges from two to three liters (1.0 to 1.5 liters each for insensible water loss by perspiration and urine production).

Water balance is maintained by various regulatory mechanisms. Water for distribution depends primarily on the concentration of electrolytes in the body compartments and sodium (Na+) plays a major role in maintaining physiologic equilibrium.

The small volume of fluid provided by Sterile Water for Injection, USP when used only as a pharmaceutic aid for diluting or dissolving drugs for parenteral injection, is unlikely to exert a significant effect on fluid balance except possibly in neonates or very small infants.

INDICATIONS AND USAGE

This parenteral preparation is indicated only for diluting or dissolving drugs for intravenous, intramuscular or subcutaneous injection, according to instructions of the manufacturer of the drug to be administered.

CONTRAINDICATIONS

Sterile Water for Injection, USP must be made approximately isotonic prior to use.

WARNINGS

Intravenous administration of Sterile Water for Injection without a solute may result in hemolysis.

PRECAUTIONS

Do not use for intravenous injection unless the osmolar concentration of additives results in an approximate isotonic admixture.

Consult the manufacturer’s instructions for choice of vehicle, appropriate dilution or volume for dissolving the drugs to be injected, including the route and rate of injection.

Inspect reconstituted (diluted or dissolved) drugs for clarity (if soluble) and freedom from unexpected precipitation or discoloration prior to administration.

Pregnancy Category C

Animal reproduction studies have not been conducted with Sterile Water for Injection. It is also not known whether sterile water containing additives can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. Sterile Water for Injection with additives should be given to a pregnant woman only if clearly needed.

Pediatric Use

Safety and effectiveness have been established in pediatric patients. However, in neonates or very small infants the volume of fluid may affect fluid and electrolyte balance.

Drug Interactions

Some drugs for injection may be incompatible in a given vehicle, or when combined in the same vehicle or in a vehicle containing benzyl alcohol. Consult with pharmacist, if available.

Use aseptic technique for single or multiple entry and withdrawal from all containers.

When diluting or dissolving drugs, mix thoroughly and use promptly.

Do not store reconstituted solutions of drugs for injection unless otherwise directed by the manufacturer of the solute.

Do not use unless the solution is clear and seal intact. Do not reuse single-dose containers. Discard unused portion.

ADVERSE REACTIONS

Reactions which may occur because of this solution, added drugs or the technique of reconstitution or administration include febrile response, local tenderness, abscess, tissue necrosis or infection at the site of injection, venous thrombosis or phlebitis extending from the site of injection and extravasation.

If an adverse reaction does occur, discontinue the infusion, evaluate the patient, institute appropriate countermeasures, and if possible, retrieve and save the remainder of the unused vehicle for examination.

OVERDOSAGE

Use only as a diluent or solvent. This parenteral preparation is unlikely to pose a threat of fluid overload except possibly in neonates or very small infants. In the event these should occur, re-evaluate the patient and institute appropriate corrective measures. See WARNINGSPRECAUTIONS and ADVERSE REACTIONS.

DOSAGE AND ADMINISTRATION

The volume of the preparation to be used for diluting or dissolving any drug for injection is dependent on the vehicle concentration, dose and route of administration as recommended by the manufacturer.

This parenteral should be inspected visually for particulate matter and discoloration prior to administration, whenever solution and container permit.

HOW SUPPLIED

Sterile Water for Injection, USP is supplied in the following:
    10 mL single dose vials packaged in cartons of 10 vials (NDC 0641-6147-10) and 25 vials (NDC 0641-6147-25)

Storage

Store at 20° to 25°C (68° to 77°F) [See USP Controlled Room Temperature.]  DO NOT FREEZE.

To report SUSPECTED ADVERSE REACTIONS, contact Hikma Pharmaceuticals USA Inc. at 1-877-845-0689, or the FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

For Product Inquiry call 1-877-845-0689.

Manufactured by:

Hikma Pharmaceuticals USA Inc.

Berkeley Heights, NJ 07922

Revised July 2020

462-682-02

PRINCIPAL DISPLAY PANEL

WARNINGS: NOT ISOTONIC. HEMOLYTIC.
NDC 0641-6147-01          Rx only
Sterile Water
for Injection, USP
FOR DRUG DILUENT USE ONLY
10 mL Single Dose Vial

10 ml vial

NDC 0641-6147-25     Rx only
Sterile Water
for Injection, USP
FOR DRUG DILUENT USE ONLY
25 x 10 mL Single Dose Vials

25 x 10 ml vial

PRINCIPAL DISPLAY PANEL

NDC 0641-6147-10       Rx only
Sterile Water
for Injection, USP
FOR DRUG DILUENT USE ONLY
10 x 10 mL Single Dose Vials

 

shelfpack

SERIALIZATION IMAGE

Layout 1

STERILE WATER 
water injection, solution
Product Information
Product TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:0641-6147
Route of AdministrationINTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
WATER (UNII: 059QF0KO0R) (WATER - UNII:059QF0KO0R) WATER1 mL  in 1 mL
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:0641-6147-1010 in 1 CARTON09/03/2015
1NDC:0641-6147-0110 mL in 1 VIAL; Type 0: Not a Combination Product
2NDC:0641-6147-2525 in 1 CARTON09/03/2015
2NDC:0641-6147-0110 mL in 1 VIAL; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
ANDAANDA20636909/03/2015
Labeler - Hikma Pharmaceuticals USA Inc. (946499746)
Establishment
NameAddressID/FEIBusiness Operations
Hikma Pharmaceuticals USA Inc.946499746analysis(0641-6147) , label(0641-6147) , manufacture(0641-6147) , pack(0641-6147)

Revised: 4/2023
Document Id: ff973eea-019f-4448-8175-0a13fb8839fc
Set id: 78ef7ad3-451d-43d0-a9b6-5cf0aadca003
Version: 11
Effective Time: 20230407
 
Hikma Pharmaceuticals USA Inc.